ObjectivesThe concurrent implementation of targeted (tPITC) and blanket provider-initiated testing and counselling (bPITC) is recommended by the World Health Organization (WHO) for HIV case-finding in generalized HIV epidemics. This study assessed the effectiveness of this intervention compared to symptom-based diagnostic HIV testing (DHT) in terms of HIV testing uptake, case detection and antiretroviral therapy (ART) enrollment among children and adolescents in Cameroon, where estimated HIV prevalence is relatively low at 3.7%.MethodsIn three hospitals where DHT was the standard practice before, tPITC and bPITC were implemented by inviting HIV-positive parents in care at the ART clinics to have their biological children (6 weeks-19 years) ...
Background: Nigeria has the second highest burden of HIV in children younger than 15 years (220 000)...
Abstract Background The HIV prevalence in Malawi is 12% and Kamuzu Central Hospital (KCH), in the ca...
BACKGROUND:There are limited data on protease inhibitor (PI)-based antiretroviral therapy (ART) amon...
ObjectivesThe concurrent implementation of targeted (tPITC) and blanket provider-initiated testing a...
Objectives The concurrent implementation of targeted (tPITC) and blanket provider-initiated testing ...
Abstract Background Children and adolescents still lag behind adults in accessing antiretroviral the...
BACKGROUND:There is a growing body of evidence positioning targeted provider-initiated testing and c...
Abstract Background Universal HIV testing and treatment of infected children remain challenging in r...
Background: There is a growing body of evidence positioning targeted provider-initiated testing and ...
Background: Provider Initiated Testing and Counseling (PITC) encourage early detection of Human Immu...
OBJECTIVE: HIV testing is the entry point to access HIV care. For HIV-infected children who survive ...
Routine HIV testing, called provider-initiated opt-out HIV testing and counseling (PITC), is recomme...
BACKGROUND:: Scale-up to antiretroviral therapy (ART) requires surveillance for HIV drug resistance....
Introduction: In recent years children and adolescents have emerged as a priority for HIV prevention...
To optimize HIV testing resources, programs are moving away from universal testing strategies toward...
Background: Nigeria has the second highest burden of HIV in children younger than 15 years (220 000)...
Abstract Background The HIV prevalence in Malawi is 12% and Kamuzu Central Hospital (KCH), in the ca...
BACKGROUND:There are limited data on protease inhibitor (PI)-based antiretroviral therapy (ART) amon...
ObjectivesThe concurrent implementation of targeted (tPITC) and blanket provider-initiated testing a...
Objectives The concurrent implementation of targeted (tPITC) and blanket provider-initiated testing ...
Abstract Background Children and adolescents still lag behind adults in accessing antiretroviral the...
BACKGROUND:There is a growing body of evidence positioning targeted provider-initiated testing and c...
Abstract Background Universal HIV testing and treatment of infected children remain challenging in r...
Background: There is a growing body of evidence positioning targeted provider-initiated testing and ...
Background: Provider Initiated Testing and Counseling (PITC) encourage early detection of Human Immu...
OBJECTIVE: HIV testing is the entry point to access HIV care. For HIV-infected children who survive ...
Routine HIV testing, called provider-initiated opt-out HIV testing and counseling (PITC), is recomme...
BACKGROUND:: Scale-up to antiretroviral therapy (ART) requires surveillance for HIV drug resistance....
Introduction: In recent years children and adolescents have emerged as a priority for HIV prevention...
To optimize HIV testing resources, programs are moving away from universal testing strategies toward...
Background: Nigeria has the second highest burden of HIV in children younger than 15 years (220 000)...
Abstract Background The HIV prevalence in Malawi is 12% and Kamuzu Central Hospital (KCH), in the ca...
BACKGROUND:There are limited data on protease inhibitor (PI)-based antiretroviral therapy (ART) amon...